PD Dr. Hans Jürgen Rech

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

PHYSICAL FUNCTION IN RA PATIENTS IN REMISSION UNDERGOING TAPERING AND/OR STOPPING OF DMARDS (2019) Stephan M, Tascilar K, Hagen M, Haschka J, Reiser M, Kleyer A, Manger B, et al. Conference contribution ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL (2019) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution T2 Mapping as a New Method for Quantitative Assessment of Cartilage Damage in RA (2019) Renner N, Kleyer A, Krönke G, Simon D, Söllner S, Rech J, Uder M, et al. Journal article Towards a pro-resolving concept in systemic lupus erythematosus (2019) Böltz S, Hagen M, Knopf J, Mahajan A, Schick M, Zhao Y, Erfurt-Berge C, et al. Journal article, Review article Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis (2019) Finzel S, Kraus S, Figueiredo CP, Regensburger A, Kocijan R, Rech J, Schett G Journal article Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis (2019) Hannemann N, Cao S, Eriksson D, Schnelzer A, Jordan J, Eberhardt M, Schleicher U, et al. Journal article The ageing joint-standard age- and sex-related values of bone erosions and osteophytes in the hand joints of healthy individuals (2019) Berlin A, Simon D, Tascilar K, Figueiredo C, Bayat S, Finzel S, Klaus E, et al. Journal article Cost-effective tapering algorithm in patients with rheumatoid arthritis: Combination of multibiomarker disease activity score and autoantibody status (2019) Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, et al. Journal article Glucocorticoid Doses and Acute-Phase Reactants at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab (2019) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Journal article Secukinumab in the treatment of psoriatic arthritis: Efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial (2018) Mease PJ, Kavanaugh A, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al. Journal article